For decades, scientists have fought cancer by developing small molecules to inhibit kinase enzymes. These enzymes play an important role in a host of cellular processes, including phosphorylation and ...
Scientists at St. Jude Children's Research Hospital have characterized a hidden intermediate state at the center of Src ...
News-Medical.Net on MSN
Hidden kinase state enables rapid and repeated protein phosphorylation
Scientists at St. Jude Children's Research Hospital have characterized a hidden intermediate state at the center of Src kinase function. This hidden state allows the kinase to repeatedly modify its ...
Clinical Trials Arena on MSN
Ipsen’s ultra-rare bone disease drug flops in Phase II trial
Ipsen’s failure comes shortly after Regeneron’s FOP study met its endpoints, sparking an FDA approval submission.
News Medical on MSN
AI-guided discovery of selective DGKα inhibitors to overcome checkpoint resistance in solid cancers
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback